Cencora Other Long-Term Assets 2010-2025 | COR
Cencora other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Cencora other long-term assets for the quarter ending March 31, 2025 were $4.168B, a 16.89% increase year-over-year.
- Cencora other long-term assets for 2024 were $3.637B, a 6.4% increase from 2023.
- Cencora other long-term assets for 2023 were $3.418B, a 94.03% increase from 2022.
- Cencora other long-term assets for 2022 were $1.762B, a 1.8% decline from 2021.
| Cencora Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $3,637 |
| 2023 | $3,418 |
| 2022 | $1,762 |
| 2021 | $1,794 |
| 2020 | $780 |
| 2019 | $269 |
| 2018 | $271 |
| 2017 | $338 |
| 2016 | $296 |
| 2015 | $298 |
| 2014 | $351 |
| 2013 | $222 |
| 2012 | $117 |
| 2011 | $129 |
| 2010 | $129 |
| 2009 | $141 |
| Cencora Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4,168 |
| 2024-12-31 | $3,889 |
| 2024-09-30 | $3,637 |
| 2024-06-30 | $3,530 |
| 2024-03-31 | $3,566 |
| 2023-12-31 | $3,459 |
| 2023-09-30 | $3,418 |
| 2023-06-30 | $3,396 |
| 2023-03-31 | $1,880 |
| 2022-12-31 | $1,802 |
| 2022-09-30 | $1,762 |
| 2022-06-30 | $1,832 |
| 2022-03-31 | $1,806 |
| 2021-12-31 | $1,796 |
| 2021-09-30 | $1,794 |
| 2021-06-30 | $1,669 |
| 2021-03-31 | $1,200 |
| 2020-12-31 | $771 |
| 2020-09-30 | $780 |
| 2020-06-30 | $800 |
| 2020-03-31 | $800 |
| 2019-12-31 | $773 |
| 2019-09-30 | $269 |
| 2019-06-30 | $272 |
| 2019-03-31 | $274 |
| 2018-12-31 | $272 |
| 2018-09-30 | $271 |
| 2018-06-30 | $288 |
| 2018-03-31 | $298 |
| 2017-12-31 | $335 |
| 2017-09-30 | $338 |
| 2017-06-30 | $313 |
| 2017-03-31 | $324 |
| 2016-12-31 | $295 |
| 2016-09-30 | $296 |
| 2016-06-30 | $305 |
| 2016-03-31 | $302 |
| 2015-12-31 | $282 |
| 2015-09-30 | $298 |
| 2015-06-30 | $357 |
| 2015-03-31 | $371 |
| 2014-12-31 | $352 |
| 2014-09-30 | $351 |
| 2014-06-30 | $368 |
| 2014-03-31 | $255 |
| 2013-12-31 | $242 |
| 2013-09-30 | $222 |
| 2013-06-30 | $158 |
| 2013-03-31 | $112 |
| 2012-12-31 | $124 |
| 2012-09-30 | $117 |
| 2012-06-30 | $125 |
| 2012-03-31 | $130 |
| 2011-12-31 | $126 |
| 2011-09-30 | $129 |
| 2011-06-30 | $129 |
| 2011-03-31 | $123 |
| 2010-12-31 | $122 |
| 2010-09-30 | $129 |
| 2010-06-30 | $131 |
| 2010-03-31 | $135 |
| 2009-12-31 | $141 |
| 2009-09-30 | $141 |
| 2009-06-30 | $147 |
| 2009-03-31 | $123 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $57.242B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.921B | 26.99 |
| Elevance Health (ELV) | United States | $89.416B | 11.54 |
| CVS Health (CVS) | United States | $88.020B | 10.94 |
| DiDi Global (DIDIY) | China | $22.544B | 23.95 |
| Labcorp Holdings (LH) | United States | $22.119B | 17.94 |
| Natera (NTRA) | United States | $21.946B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.094B | 0.00 |
| Solventum (SOLV) | United States | $13.476B | 14.27 |
| CochLear (CHEOY) | Australia | $12.827B | 0.00 |
| ICON (ICLR) | Ireland | $12.023B | 11.18 |
| Revvity (RVTY) | United States | $11.673B | 20.09 |
| Viatris (VTRS) | United States | $10.774B | 3.70 |
| Avantor (AVTR) | United States | $9.486B | 13.78 |
| Medpace Holdings (MEDP) | United States | $9.228B | 24.51 |
| HealthEquity (HQY) | United States | $8.897B | 38.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.498B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.583B | 14.86 |
| Caris Life Sciences,�Inc (CAI) | $6.744B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.758B | 28.02 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.250B | 18.47 |
| Surgery Partners (SGRY) | United States | $2.890B | 37.58 |
| Alignment Healthcare (ALHC) | United States | $2.811B | 0.00 |
| Concentras Parent (CON) | United States | $2.671B | 15.44 |
| Organon (OGN) | United States | $2.613B | 2.78 |
| GeneDx Holdings (WGS) | United States | $2.576B | 99.22 |
| PACS (PACS) | United States | $1.974B | 0.00 |
| Ardent Health (ARDT) | United States | $1.964B | 8.37 |
| Progyny (PGNY) | United States | $1.891B | 41.62 |
| Premier (PINC) | United States | $1.789B | 13.58 |
| GoodRx Holdings (GDRX) | United States | $1.772B | 35.43 |
| Teladoc Health (TDOC) | United States | $1.505B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.255B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.231B | 9.37 |
| CareDx (CDNA) | United States | $1.050B | 16.39 |
| Agilon Health (AGL) | United States | $0.985B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.842B | 7.88 |
| QDM (QDMI) | Hong Kong, SAR China | $0.776B | 0.00 |
| Nutex Health (NUTX) | United States | $0.732B | 11.09 |
| Embecta (EMBC) | United States | $0.600B | 4.04 |
| LifeMD (LFMD) | United States | $0.597B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.533B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Omada Health (OMDA) | $0.470B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 32.83 |
| Performant Healthcare (PHLT) | United States | $0.322B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.296B | 0.00 |
| So-Young (SY) | China | $0.288B | 0.00 |
| Beauty Health (SKIN) | United States | $0.272B | 0.00 |
| Oncology Institute (TOI) | United States | $0.196B | 0.00 |
| DocGo (DCGO) | United States | $0.155B | 25.33 |
| Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
| KindlyMD (NAKA) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.030B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.029B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.020B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |